Table 1.
Baseline characteristics at the time of starting insulin of people with type 2 diabetes included in the CREDIT study.
| n | Median (interquartile range) or % | |
|---|---|---|
| Sex: male | 1534 | 51.2 |
| Age (years) | 2999 | 61 (54–69) |
| HbA1c | 2925 | 9.3 (8.1–10.7) |
| Duration of diabetes (years) | 2985 | 9.0 (5.0–14.5) |
| Previous diagnosis of high BP | 2056 | 68.6 |
| Systolic BP (mmHg) | 2749 | 138 (127–150) |
| Diastolic BP (mmHg) | 2750 | 80 (72–90) |
| Body mass index (kg/m2) | 2796 | 28.6 (24.8–32.8) |
| Physically active, yes | 1415 | 47.4 |
| Smoking status | ||
| Never smoked | 1667 | 55.9 |
| Stopped ≥1 year ago | 758 | 25.4 |
| Stopped <1 year ago | 104 | 3.5 |
| Currently smoke | 455 | 15.3 |
| Family history of premature CV disease | 757 | 25.6 |
| ≥1 macrovascular disease | 1025 | 34.2 |
| ≥1 microvascular disease | 2085 | 69.5 |
| Glucose‐lowering therapies | 2999 | 1 (0–2) |
| ≥1 BP‐lowering drug | 2164 | 72.2 |
| Antiplatelet/anticoagulant | 1231 | 41.1 |
| Statin/fibrate | 1356 | 45.2 |
| Region | ||
| North America | 735 | 24.5 |
| Eastern Europe | 647 | 21.6 |
| Southern Europe | 460 | 15.3 |
| France | 511 | 17.0 |
| Northern Europe | 252 | 8.4 |
| Japan | 394 | 13.1 |
BP, blood pressure; CV, cardiovascular; HbA1c, glycated haemoglobin.
Physical activity was defined as patient involved in walking, cycling or gardening for ≥4 h a week.